Literature DB >> 20720356

Premature atrial contraction induces torsades de pointes in a patient of Takotsubo cardiomyopathy with QT prolongation.

Hiroaki Kawano1, Yuji Matsumoto, Shuji Arakawa, Osami Satoh, Motonobu Hayano.   

Abstract

Although the prognosis for patients with stress-induced cardiomyopathy (Takotsubo cardiomyopathy) is relatively good, some patients with this syndrome develop torsades de pointes, which can be fatal. The present report describes a patient with Takotsubo cardiomyopathy and torsades de pointes induced by premature atrial contraction associated with QT interval prolongation, hypokalemia and hypomagnesemia.

Entities:  

Mesh:

Year:  2010        PMID: 20720356     DOI: 10.2169/internalmedicine.49.3237

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Initial clinical presentation of Takotsubo cardiomyopathy with-a focus on electrocardiographic changes: A literature review of cases.

Authors:  Erick Francisco Sanchez-Jimenez
Journal:  World J Cardiol       Date:  2013-07-26

2.  A case of Takotsubo cardiomyopathy showing two modes of initiation for ventricular fibrillation: Augmented J-wave and torsade de pointes with QT prolongation.

Authors:  Masato Shimizu; Mitsuhiro Nishizaki; Noriyoshi Yamawake; Hiroyuki Fujii; Harumizu Sakudara; Masayasu Hiraoka
Journal:  HeartRhythm Case Rep       Date:  2016-07-14

3.  Amiodarone-induced life-threatening torsade de pointes in an end-stage lung cancer patient receiving gefitinib.

Authors:  Dan Han; Hui Tan; Chaofeng Sun; Guoliang Li
Journal:  Oxf Med Case Reports       Date:  2019-01-24

4.  Premature atrial contractions with multiple patterns of aberrant conduction followed by torsade de pointes in a patient with polymyalgia rheumatica: A case report.

Authors:  Koji Takahashi; Mina Yamashita; Tomoki Sakaue; Daijiro Enomoto; Shigeki Uemura; Takafumi Okura; Shuntaro Ikeda; Masafumi Takemoto; Yutaka Utsunomiya; Takashi Hyodo; Masayuki Ochi; Satoshi Higuchi
Journal:  Medicine (Baltimore)       Date:  2021-09-17       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.